These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 17996568)

  • 1. F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2).
    Beanlands RS; Nichol G; Huszti E; Humen D; Racine N; Freeman M; Gulenchyn KY; Garrard L; deKemp R; Guo A; Ruddy TD; Benard F; Lamy A; Iwanochko RM;
    J Am Coll Cardiol; 2007 Nov; 50(20):2002-12. PubMed ID: 17996568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Follow-Up of Outcomes With F-18-Fluorodeoxyglucose Positron Emission Tomography Imaging-Assisted Management of Patients With Severe Left Ventricular Dysfunction Secondary to Coronary Disease.
    Mc Ardle B; Shukla T; Nichol G; deKemp RA; Bernick J; Guo A; Lim SP; Davies RA; Haddad H; Duchesne L; Hendry P; Masters R; Ross H; Freeman M; Gulenchyn K; Racine N; Humen D; Benard F; Ruddy TD; Chow BJ; Mielniczuk L; DaSilva JN; Garrard L; Wells GA; Beanlands RS;
    Circ Cardiovasc Imaging; 2016 Sep; 9(9):. PubMed ID: 27609816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 18F-FDG PET imaging of myocardial viability in an experienced center with access to 18F-FDG and integration with clinical management teams: the Ottawa-FIVE substudy of the PARR 2 trial.
    Abraham A; Nichol G; Williams KA; Guo A; deKemp RA; Garrard L; Davies RA; Duchesne L; Haddad H; Chow B; DaSilva J; Beanlands RS;
    J Nucl Med; 2010 Apr; 51(4):567-74. PubMed ID: 20237039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increasing benefit from revascularization is associated with increasing amounts of myocardial hibernation: a substudy of the PARR-2 trial.
    D'Egidio G; Nichol G; Williams KA; Guo A; Garrard L; deKemp R; Ruddy TD; DaSilva J; Humen D; Gulenchyn KY; Freeman M; Racine N; Benard F; Hendry P; Beanlands RS;
    JACC Cardiovasc Imaging; 2009 Sep; 2(9):1060-8. PubMed ID: 19761983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of outcome and cost-effectiveness using an FDG PET-guided approach to management of patients with coronary disease and severe left ventricular dysfunction (PARR-2): rationale, design, and methods.
    Beanlands R; Nichol G; Ruddy TD; deKemp RA; Hendry P; Humen D; Racine N; Ross H; Benard F; Coates G; Iwanochko RM; Fallen E; Wells G;
    Control Clin Trials; 2003 Dec; 24(6):776-94. PubMed ID: 14662282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does FDG PET-assisted management of patients with left ventricular dysfunction improve quality of life? A substudy of the PARR-2 trial.
    Shukla T; Nichol G; Wells G; deKemp RA; Davies RA; Haddad H; Duchesne L; Freeman M; Gulenchyn K; Racine N; Humen D; Benard F; Ruddy TD; Chow BJ; DaSilva J; Garrard L; Guo A; Chen L; Beanlands RS
    Can J Cardiol; 2012; 28(1):54-61. PubMed ID: 22138342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcome of patients with previous myocardial infarction and left ventricular dysfunction assessed with myocardial (99m)Tc-MIBI SPECT and (18)F-FDG PET.
    Zhang X; Liu XJ; Wu Q; Shi R; Gao R; Liu Y; Hu S; Tian Y; Guo S; Fang W
    J Nucl Med; 2001 Aug; 42(8):1166-73. PubMed ID: 11483675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delay in revascularization is associated with increased mortality rate in patients with severe left ventricular dysfunction and viable myocardium on fluorine 18-fluorodeoxyglucose positron emission tomography imaging.
    Beanlands RS; Hendry PJ; Masters RG; deKemp RA; Woodend K; Ruddy TD
    Circulation; 1998 Nov; 98(19 Suppl):II51-6. PubMed ID: 9852880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of contrast-enhanced MRI with (18)F-FDG PET/201Tl SPECT in dysfunctional myocardium: relation to early functional outcome after surgical revascularization in chronic ischemic heart disease.
    Wu YW; Tadamura E; Yamamuro M; Kanao S; Marui A; Tanabara K; Komeda M; Togashi K
    J Nucl Med; 2007 Jul; 48(7):1096-103. PubMed ID: 17607039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial viability testing and the effect of early intervention in patients with advanced left ventricular systolic dysfunction.
    Tarakji KG; Brunken R; McCarthy PM; Al-Chekakie MO; Abdel-Latif A; Pothier CE; Blackstone EH; Lauer MS
    Circulation; 2006 Jan; 113(2):230-7. PubMed ID: 16391157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positron emission tomography using(18)F-fluoro-deoxyglucose and euglycaemic hyperinsulinaemic glucose clamp: optimal criteria for the prediction of recovery of post-ischaemic left ventricular dysfunction. Results from the European Community Concerted Action Multicenter study on use of(18)F-fluoro-deoxyglucose Positron Emission Tomography for the Detection of Myocardial Viability.
    Gerber BL; Ordoubadi FF; Wijns W; Vanoverschelde JL; Knuuti MJ; Janier M; Melon P; Blanksma PK; Bol A; Bax JJ; Melin JA; Camici PG
    Eur Heart J; 2001 Sep; 22(18):1691-701. PubMed ID: 11511119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positron emission tomography and recovery following revascularization (PARR-1): the importance of scar and the development of a prediction rule for the degree of recovery of left ventricular function.
    Beanlands RS; Ruddy TD; deKemp RA; Iwanochko RM; Coates G; Freeman M; Nahmias C; Hendry P; Burns RJ; Lamy A; Mickleborough L; Kostuk W; Fallen E; Nichol G;
    J Am Coll Cardiol; 2002 Nov; 40(10):1735-43. PubMed ID: 12446055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of diabetes mellitus on prediction of clinical outcome after coronary revascularization by 18F-FDG SPECT in patients with ischemic left ventricular dysfunction.
    Schinkel AF; Poldermans D; Rizzello V; van Domburg RT; Valkema R; Elhendy A; Biagini E; Krenning EP; Simoons ML; Bax JJ
    J Nucl Med; 2006 Jan; 47(1):68-73. PubMed ID: 16391189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The extent of perfusion-F18-fluorodeoxyglucose positron emission tomography mismatch determines mortality in medically treated patients with chronic ischemic left ventricular dysfunction.
    Desideri A; Cortigiani L; Christen AI; Coscarelli S; Gregori D; Zanco P; Komorovsky R; Bax JJ
    J Am Coll Cardiol; 2005 Oct; 46(7):1264-9. PubMed ID: 16198841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of optimum periods between onset of suspected acute myocarditis and ¹⁸F-fluorodeoxyglucose positron emission tomography in the diagnosis of inflammatory left ventricular myocardium.
    Ozawa K; Funabashi N; Daimon M; Takaoka H; Takano H; Uehara M; Kobayashi Y
    Int J Cardiol; 2013 Nov; 169(3):196-200. PubMed ID: 24075573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term survival of patients with coronary artery disease and left ventricular dysfunction: implications for the role of myocardial viability assessment in management decisions.
    Di Carli MF; Maddahi J; Rokhsar S; Schelbert HR; Bianco-Batlles D; Brunken RC; Fromm B
    J Thorac Cardiovasc Surg; 1998 Dec; 116(6):997-1004. PubMed ID: 9832692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial glucose utilization and optimization of (18)F-FDG PET imaging in patients with non-insulin-dependent diabetes mellitus, coronary artery disease, and left ventricular dysfunction.
    Vitale GD; deKemp RA; Ruddy TD; Williams K; Beanlands RS
    J Nucl Med; 2001 Dec; 42(12):1730-6. PubMed ID: 11752067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of myocardial viability and coronary revascularization on clinical outcome and prognosis: a follow-up study of 161 patients with coronary heart disease].
    vom Dahl J; Altehoefer C; Büchin P; Sheehan FH; Schwarz ER; Koch KC; Schulz G; Uebis R; Schöndube F; Messmer BJ; Büll U; Hanrath P
    Z Kardiol; 1996 Nov; 85(11):868-81. PubMed ID: 9064949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scar imaging using multislice computed tomography versus metabolic imaging by F-18 FDG positron emission tomography: a pilot study.
    Dwivedi G; Al-Shehri H; deKemp RA; Ali I; Alghamdi AA; Klein R; Scullion A; Ruddy TD; Beanlands RS; Chow BJ
    Int J Cardiol; 2013 Sep; 168(2):739-45. PubMed ID: 23102604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-FDG PET for detecting myocardial viability: validation of 3D data acquisition.
    Brogsitter C; Grüning T; Weise R; Wielepp P; Lindner O; Körfer R; Burchert W
    J Nucl Med; 2005 Jan; 46(1):19-24. PubMed ID: 15632028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.